Sean Wieland
Stock Analyst at Piper Sandler
(1.39)
# 3,179
Out of 4,829 analysts
29
Total ratings
40%
Success rate
-0.13%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Maintains: Overweight | $25 → $40 | $25.02 | +59.87% | 2 | Feb 28, 2025 | |
| OMCL Omnicell | Upgrades: Overweight | $70 → $39 | $25.78 | +51.28% | 11 | Nov 3, 2023 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $6.84 | +1,654.39% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $51.96 | -88.45% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $59.19 | -25.66% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $148.99 | +55.04% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $7.11 | +3,992.83% | 5 | Feb 25, 2021 |
Privia Health Group
Feb 28, 2025
Maintains: Overweight
Price Target: $25 → $40
Current: $25.02
Upside: +59.87%
Omnicell
Nov 3, 2023
Upgrades: Overweight
Price Target: $70 → $39
Current: $25.78
Upside: +51.28%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $6.84
Upside: +1,654.39%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $51.96
Upside: -88.45%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $59.19
Upside: -25.66%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $148.99
Upside: +55.04%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $7.11
Upside: +3,992.83%